Skip to content

SCHEDULE 13G/AAccepted Feb 17, 6:51 PM ET

Kyverna Therapeutics, Inc. SCHEDULE 13G/A

Northpond Ventures III, LP

Accepted (ET)

6:51 PM

Feb 17, 2026

Filed

Feb 17, 2026

Documents

2

Size

23.3 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.